Result of AGM

RNS Number : 6796M

Yourgene Health PLC

17 September 2019

 

Yourgene Health plc

("Yourgene" or the "Company")

Result of AGM

Manchester, UK - 17 September 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that, at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

Details of the proxy votes received from shareholders on each resolution will be available on the Company's website: https://www.yourgene-health.com/investors/key-documents/shareholder-communications 

Yourgene Health plc Lyn Rees, Chief Executive Officer Barry Hextall, Chief Financial Officer Joanne Cross, Director of Marketing	Tel: [phone] [e-mail]
Cairn Financial Advisers LLP (NOMAD) Liam Murray / James Caithie / Ludovico Lazzaretti	Tel: [phone]
Stifel Nicolaus Europe Limited (Sole Corporate Broker) Nicholas Moore / Matthew Blawat / Ben Maddison		Tel: [phone]
Walbrook PR Ltd (Media and Investor Relations) Paul McManus / Lianne Cawthorne / Anna Dunphy	Tel: [phone] or [e-mail] Mob: [phone]

About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. 

Yourgene develops and commercialises simple and accurate molecular diagnostic solutions, primarily for reproductive health. The Group's products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, male infertility tests and genetic disease tests. Yourgene's commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.

Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions. Through our technical expertise and partnerships, Yourgene Health is also extending its genetic testing offering into oncology.

Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information, visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.

 

END

 

 

RAGCKODQABKDFCD